Scott D Barton

US Patent:

20230020306, Jan 19, 2023

Filed:

Sep 23, 2022

Appl. No.:

17/951801

Inventors:

- Tarrytown NY, US
Scott BARTON - Clifton Park NY, US
Bart E. BURGESS - Bernville PA, US
Alexei GORALTCHOUK - Cambridge MA, US

Assignee:

Regeneron Pharmaceuticals, Inc. - Tarrytown NY

International Classification:

A61M 5/31
A61M 5/32

Abstract:

The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, wherein the cap may include a central longitudinal axis, a first end having a first cross-sectional dimension, and a second end having a second cross-sectional dimension larger than the first cross-sectional dimension. The cap may further include a curved sidewall extending radially outward from the first end to the second end, and the curved sidewall may include a protrusion.

US Patent:

20200139050, May 7, 2020

Filed:

Jun 29, 2018

Appl. No.:

16/626669

Inventors:

- Tarrytown NY, US
Scott BARTON - East Greenbush NY, US
Bart E. BURGESS - East Greenbush NY, US
Alexei GORALTCHOUK - Cambridge MA, US

Assignee:

Regeneron Pharmaceuticals, Inc. - Tarrytown NY

International Classification:

A61M 5/31
A61M 5/32

Abstract:

The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, which may include a curved sidewall extending radially outward. The curved sidewall may include a protrusion.